Monday, October 6, 2025

Latest

Medipharm Labs Closes $33.4 Million Bought Deal Financing

Medipharm Labs (TSX: LABS) has closed the bought deal financing that it announced and then later upsized earlier this week. The company managed to raise total gross proceeds of $33.4 million under the financing.

The financing saw units of the company sold at a price of $0.58, with each unit containing one common share and one common share purchase warrant. Each warrant is valid for a period of 2 years from the date of issuance at a price of $0.70 per common share.

The financing saw a total of 57.5 million units sold, while the over-allotment option was exercised in full.

Proceeds from the financing are to be used to expand the firms product portfolio, pharmaceutical registrations, R&D for clinical trials, sales and marketing, as well as working capital and general corporate purposes.

Medipharm Labs last traded at $0.49 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Medipharm Labs Posts Revenues of $13.9 Million, Net Loss of $3.5 Million For Q2 2020

Medipharm Labs (TSX: LABS) reported further disappointing quarterly results this morning, with revenues of $13.9...

Thursday, August 13, 2020, 09:25:18 AM

Medipharm Labs and TerrAscend Corp Enter $27 Million Cannabis Distillate Agreement

Medipharm Labs (TSX: LABS) and TerrAscend Corp (CSE: TER) announced a significant transaction this morning,...

Wednesday, September 25, 2019, 08:56:45 AM

Medipharm Announces White Label Agreement With Argentia Gold

Medipharm Labs (TSX: LABS) and Argentia Gold Corp this morning jointly announced a supply agreement,...

Wednesday, May 27, 2020, 08:34:11 AM

Medipharm Labs Sees PI Financial, Mackie Research Drop Estimates, Price Targets

Medipharm Labs (TSX: LABS) reported Q1 2020 results on Thursday, June 18, which showed it’s...

Friday, June 19, 2020, 02:55:31 PM

MediPharm Labs Posts Q3 Revenues of $5.4 Million, Continues To Post Negative Gross Margins

MediPharm Labs (TSX: LABS) this morning reported its third quarter financial results, posting revenues of...

Monday, November 15, 2021, 08:54:23 AM